143 related articles for article (PubMed ID: 7603511)
1. Mitochondrial DNA mutation and muscle pathology in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.
Mita S; Tokunaga M; Kumamoto T; Uchino M; Nonaka I; Ando M
Muscle Nerve Suppl; 1995; 3():S113-8. PubMed ID: 7603511
[TBL] [Abstract][Full Text] [Related]
2. Single muscle fiber analysis of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
Tokunaga M; Mita S; Murakami T; Kumamoto T; Uchino M; Nonaka I; Ando M
Ann Neurol; 1994 Apr; 35(4):413-9. PubMed ID: 8154867
[TBL] [Abstract][Full Text] [Related]
3. Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
Tokunaga M; Mita S; Sakuta R; Nonaka I; Araki S
Ann Neurol; 1993 Mar; 33(3):275-80. PubMed ID: 7684581
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of MELAS and mitochondrial DNA mutations.
Goto Y
Muscle Nerve Suppl; 1995; 3():S107-12. PubMed ID: 7603510
[TBL] [Abstract][Full Text] [Related]
5. Single muscle fiber analysis of myoclonus epilepsy with ragged-red fibers.
Mita S; Tokunaga M; Uyama E; Kumamoto T; Uekawa K; Uchino M
Muscle Nerve; 1998 Apr; 21(4):490-7. PubMed ID: 9533783
[TBL] [Abstract][Full Text] [Related]
6. Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype.
Melone MA; Tessa A; Petrini S; Lus G; Sampaolo S; di Fede G; Santorelli FM; Cotrufo R
Arch Neurol; 2004 Feb; 61(2):269-72. PubMed ID: 14967777
[TBL] [Abstract][Full Text] [Related]
7. The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle.
Moraes CT; Ricci E; Bonilla E; DiMauro S; Schon EA
Am J Hum Genet; 1992 May; 50(5):934-49. PubMed ID: 1315123
[TBL] [Abstract][Full Text] [Related]
8. A molecular genetic study of focal histochemical defects in mitochondrial encephalomyopathies.
Hammans SR; Sweeney MG; Wicks DA; Morgan-Hughes JA; Harding AE
Brain; 1992 Apr; 115 ( Pt 2)():343-65. PubMed ID: 1606473
[TBL] [Abstract][Full Text] [Related]
9. Sporadic MERRF/MELAS overlap syndrome associated with the 3243 tRNA(Leu(UUR)) mutation of mitochondrial DNA.
Campos Y; Martin MA; Lorenzo G; Aparicio M; Cabello A; Arenas J
Muscle Nerve; 1996 Feb; 19(2):187-90. PubMed ID: 8559168
[TBL] [Abstract][Full Text] [Related]
10. Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF.
Naini AB; Lu J; Kaufmann P; Bernstein RA; Mancuso M; Bonilla E; Hirano M; DiMauro S
Arch Neurol; 2005 Mar; 62(3):473-6. PubMed ID: 15767514
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome c oxidase activity is deficient in blood vessels of patients with myoclonus epilepsy with ragged-red fibers.
Hasegawa H; Matsuoka T; Goto Y; Nonaka I
Acta Neuropathol; 1993; 85(3):280-4. PubMed ID: 8384773
[TBL] [Abstract][Full Text] [Related]
12. Histochemical and molecular genetic study of MELAS and MERRF in Korean patients.
Kim DS; Jung DS; Park KH; Kim IJ; Kim CM; Lee WH; Rho SK
J Korean Med Sci; 2002 Feb; 17(1):103-12. PubMed ID: 11850598
[TBL] [Abstract][Full Text] [Related]
13. Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243.
Petruzzella V; Moraes CT; Sano MC; Bonilla E; DiMauro S; Schon EA
Hum Mol Genet; 1994 Mar; 3(3):449-54. PubMed ID: 7912129
[TBL] [Abstract][Full Text] [Related]
14. Patients with MELAS with negative myopathology for characteristic ragged-red fibers.
Lu Y; Deng J; Zhao Y; Zhang Z; Hong D; Yao S; Zhao D; Xie J; Fang H; Yuan Y; Wang Z
J Neurol Sci; 2020 Jan; 408():116499. PubMed ID: 31726383
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation.
Auré K; Fayet G; Leroy JP; Lacène E; Romero NB; Lombès A
Brain; 2006 May; 129(Pt 5):1249-59. PubMed ID: 16537564
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged-red fiber disease point mutation in mitochondrial DNA.
Graf WD; Sumi SM; Copass MK; Ojemann LM; Longstreth WT; Shanske S; Lombes A; DiMauro S
Ann Neurol; 1993 Jun; 33(6):640-5. PubMed ID: 8388680
[TBL] [Abstract][Full Text] [Related]
17. Study of mitochondrial DNA depletion in muscle by single-fiber polymerase chain reaction.
Sciacco M; Gasparo-Rippa P; Vu TH; Tanji K; Shanske S; Mendell JR; Schon EA; DiMauro S; Bonilla E
Muscle Nerve; 1998 Nov; 21(11):1374-81. PubMed ID: 9771659
[TBL] [Abstract][Full Text] [Related]
18. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations.
James AM; Wei YH; Pang CY; Murphy MP
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):401-7. PubMed ID: 8809026
[TBL] [Abstract][Full Text] [Related]
19. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement.
Betts J; Jaros E; Perry RH; Schaefer AM; Taylor RW; Abdel-All Z; Lightowlers RN; Turnbull DM
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):359-73. PubMed ID: 16866982
[TBL] [Abstract][Full Text] [Related]
20. Functional mitochondrial heterogeneity in heteroplasmic cells carrying the mitochondrial DNA mutation associated with the MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes).
Bakker A; Barthélémy C; Frachon P; Chateau D; Sternberg D; Mazat JP; Lombès A
Pediatr Res; 2000 Aug; 48(2):143-50. PubMed ID: 10926287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
